What is the treatment regimen for herpes simplex or herpes zoster using Valacyclovir in adults?

Valacyclovir Treatment Regimens for Herpes Simplex and Herpes Zoster in Adults

Herpes Zoster (Shingles)

For immunocompetent adults with herpes zoster, valacyclovir 1 gram three times daily for 7-10 days is the standard treatment, initiated within 72 hours of rash onset and continued until all lesions have completely scabbed. 1, 2

Standard Dosing Algorithm

• Uncomplicated herpes zoster: Valacyclovir 1 gram orally three times daily for 7-10 days 1, 2
• Treatment must be initiated within 72 hours of rash onset for optimal efficacy in reducing acute pain, accelerating lesion healing, and preventing postherpetic neuralgia 2
• Continue treatment until all lesions have completely scabbed, not just for an arbitrary 7-day period—this is the key clinical endpoint 2
• Alternative dosing: Valacyclovir 1.5 grams twice daily has been shown to be equally safe and effective, with the advantage of improved compliance 3

When to Escalate to Intravenous Therapy

• Disseminated herpes zoster (multi-dermatomal, visceral involvement): Switch to IV acyclovir 10 mg/kg every 8 hours 2
• Immunocompromised patients (including those on chemotherapy, HIV-infected, transplant recipients): IV acyclovir 10 mg/kg every 8 hours for minimum 7-10 days until clinical resolution 2
• Complicated facial zoster with suspected CNS involvement or severe ophthalmic disease: IV acyclovir 2
• For immunocompromised patients, consider temporary reduction in immunosuppressive medications if clinically feasible 2

Special Populations

• HIV-infected patients with CD4+ ≥100 cells/mm³: Valacyclovir 500 mg twice daily for suppressive therapy 4
• Immunocompromised patients with uncomplicated zoster: May require higher oral doses or extended duration beyond 7-10 days, as lesions develop over longer periods (7-14 days) and heal more slowly 2
• Renal impairment: Mandatory dose adjustments based on creatinine clearance to prevent acute renal failure 2

Critical Monitoring

• Monitor renal function at initiation and once or twice weekly during IV acyclovir therapy 2
• If lesions fail to begin resolving within 7-10 days, suspect acyclovir resistance and obtain viral culture with susceptibility testing 2
• For confirmed acyclovir-resistant cases: Foscarnet 40 mg/kg IV every 8 hours until clinical resolution 2

---

Herpes Simplex Infections

Cold Sores (Herpes Labialis)

For cold sores in adults and adolescents ≥12 years, valacyclovir 2 grams twice daily for 1 day is the most effective regimen, initiated at the earliest sign of prodromal symptoms. 1, 5

• First-line episodic treatment: Valacyclovir 2 grams orally twice daily for 1 day (total of 2 doses) 5, 1
• Treatment must be initiated during the prodromal phase or within 24 hours of lesion onset, as peak viral titers occur in the first 24 hours 5
• Alternative: Valacyclovir 500 mg twice daily for 3-5 days, though less convenient 5

Suppressive therapy for frequent recurrences (≥6 episodes per year):

• Valacyclovir 500 mg once daily (can increase to 1000 mg once daily for very frequent recurrences) 5
• Daily suppressive therapy reduces recurrence frequency by ≥75% 5
• Safety documented for valacyclovir up to 1 year of continuous use 5
• After 1 year, consider discontinuation to reassess recurrence frequency 5

Genital Herpes

Initial episode: Valacyclovir 1 gram orally twice daily for 7-10 days, most effective when started within 48 hours of symptom onset 1, 4

• Treatment may be extended if healing is incomplete after 10 days 4
• Efficacy when initiated >72 hours after onset has not been established 1

Recurrent episodes: Valacyclovir 500 mg orally twice daily for 3 days 1

• Efficacy when initiated >24 hours after onset has not been established 1

Suppressive therapy (immunocompetent adults):

• Valacyclovir 1 gram once daily 1
• For patients with ≤9 recurrences per year: Valacyclovir 500 mg once daily 1
• In a 12-month trial, 34% of patients remained recurrence-free on valacyclovir 1 gram once daily 1

Suppressive therapy (HIV-infected adults with CD4+ ≥100 cells/mm³):

• Valacyclovir 500 mg twice daily 1
• In a 6-month trial, 65% of HIV-infected patients remained recurrence-free on this regimen 1
• Safety beyond 6 months in HIV-infected patients has not been established 1

Reduction of transmission (discordant couples):

• Valacyclovir 500 mg once daily reduced symptomatic HSV-2 acquisition by 75% (0.5% vs 2.2% with placebo) 1
• Safer sex practices must be used concurrently 1

Severe HSV Infections Requiring Hospitalization

• Severe mucosal HSV or gingivostomatitis: IV acyclovir 5-10 mg/kg every 8 hours until lesions begin to regress, then switch to oral therapy 5
• Acyclovir-resistant HSV: IV foscarnet 40 mg/kg every 8 hours until clinical resolution 5, 4
• All acyclovir-resistant strains are also resistant to valacyclovir 4

---

Critical Caveats and Pitfalls

• Never use topical antivirals as primary therapy—they are substantially less effective than systemic therapy 2, 5
• Avoid valacyclovir doses of 8 grams per day in immunocompromised patients due to risk of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome 4, 6
• Do not discontinue antiviral therapy at exactly 7 days for herpes zoster if lesions are still forming or have not completely scabbed 2
• Starting treatment late (>72 hours for zoster, >24 hours for recurrent genital herpes) significantly reduces efficacy, though observational data suggest valacyclovir may still provide benefit when started later than 72 hours for zoster 2, 7
• Immunocompromised patients may require extended treatment duration well beyond 7-10 days, as their lesions continue to develop over longer periods and heal more slowly 2